Enteric Medical Technologies

Enteric Medical Technologies designs, manufactures, and markets minimally invasive technologies for the treatment of gastroesophageal reflux disease. It provides Enteryx, an injectable biopolymer that is injected into the esophageal wall to augment the LES. The company was founded in 1998 and is headquartered in Foster City, California. Since June 12, 2002, Enteric Medical Technologies, Inc. has been operating as a subsidiary of Boston Scientific Corporation.